Catalyst Funds Management Pty LTD Ironwood Pharmaceuticals Inc Transaction History
Catalyst Funds Management Pty LTD
- $409 Billion
- Q4 2024
A detailed history of Catalyst Funds Management Pty LTD transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Catalyst Funds Management Pty LTD holds 10,500 shares of IRWD stock, worth $16,905. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,500Holding current value
$16,905% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding IRWD
# of Institutions
244Shares Held
163MCall Options Held
11.5MPut Options Held
12.9K-
Black Rock Inc. New York, NY22.9MShares$36.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.5MShares$31.5 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$26.4 Million22.5% of portfolio
-
Pacer Advisors, Inc. Malvern, PA11.7MShares$18.9 Million0.13% of portfolio
-
Armistice Capital, LLC New York, NY9.47MShares$15.2 Million0.59% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $247M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...